---
schema_version: "secwatch.filing_event.v1"
accession: "0001370053-25-000055"
form_type: "8-K"
ticker: "ANAB"
cik: "0001370053"
company_name: "ANAPTYSBIO, INC"
filed_at: "2025-06-17T23:59:59+00:00"
generated_at: "2026-05-19T04:27:52.010745+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# AnaptysBio shareholders approve amended equity plan, elect directors at 2025 annual meeting

## Summary
- Elected Rita Jain, John Orwin, and J. Anthony Ware as Class II directors for three-year terms with over 21M votes for each.
- Approved amendment to 2017 Equity Incentive Plan with 18.0M for, 6.4M against; increases share reserve to 13.5M shares.
- Ratified KPMG as independent auditor for FY2025 with 27.2M votes for, 17K against.
- Advisory say-on-pay passed with 17.8M for, 6.6M against; shareholders preferred one-year frequency for future votes.

## SEC filing metadata
- accession: 0001370053-25-000055
- form_type: 8-K
- ticker: ANAB
- cik: 0001370053
- company_name: ANAPTYSBIO, INC
- filed_at: 2025-06-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1370053/000137005325000055/0001370053-25-000055-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1370053/000137005325000055/anab-20250617.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001370053-25-000055
- JSON: https://secwatch.observer/filing/0001370053-25-000055.json
- Plain text: https://secwatch.observer/filing/0001370053-25-000055.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.